Ciprofloxacin 250 MG Oral Tablet — RxCUI 197511
RxNorm drug concept · Semantic clinical drug
RxCUI 197511
Semantic clinical drug · SCD
● Current RxNorm concept 88 FDA products
280 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197511
Official nameCiprofloxacin 250 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asciprofloxacin 250 MG (as ciprofloxacin HCl 297 MG) Oral Tablet
FDA products mapped88
Package NDCs mapped280
Reported Medicaid activity (SDUD)766,193 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ciprofloxacin Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- These drops are an antibiotic specifically for bacterial eye infections. They're approved to treat two conditions: bacterial conjunctivitis — which most people call pink eye — and...
- What exactly does ciprofloxacin eye drops treat?
- Yes, especially for corneal ulcers — the schedule is intentionally intensive at the start to get the infection under control quickly. You'll be using drops very frequently the firs...
- The dosing schedule looks really complicated — do I really need to use them that often?
🕸️ Concept Web — How Ciprofloxacin 250 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ciprofloxacin 250 MG Oral Tablet
RxCUI 197511 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ciprofloxacin
2551IN
-
Ciprofloxacin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cipro
203563BN
-
Cipro
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ciprofloxacin Oral Tablet
371525SCDF -
Ciprofloxacin Oral Product
1152118SCDG -
Ciprofloxacin Pill
1152120SCDG -
Ciprofloxacin Oral Tablet [Cipro]
368093SBDF -
Cipro Oral Product
1170899SBDG -
Cipro Pill
1170900SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Ciprofloxacin Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ciprofloxacin 250 MG
328286SCDC -
Ciprofloxacin 250 MG Oral Tablet [Cipro]
205769SBD -
Ciprofloxacin 250 MG [Cipro]
566659SBDC
-
Ciprofloxacin 250 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ciprofloxacin 250 MG
SCDC · 328286 -
Ciprofloxacin Oral Tablet
SCDF · 371525 -
Ciprofloxacin Oral Product
SCDG · 1152118 -
Ciprofloxacin Pill
SCDG · 1152120
Brand-Name Concepts
-
Ciprofloxacin 250 MG Oral Tablet [Cipro]
SBD · 205769 -
Ciprofloxacin 250 MG [Cipro]
SBDC · 566659 -
Ciprofloxacin Oral Tablet [Cipro]
SBDF · 368093 -
Cipro Oral Product
SBDG · 1170899 -
Cipro Pill
SBDG · 1170900 -
Cipro
BN · 203563
📦 FDA Products & Package NDCs
88 products · 280 package NDCs
280 package NDCs map to RxCUI 197511 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 76420-0928-60 | 60 TABLET in 1 BOTTLE (76420-928-60) | Ciprofloxacin | Asclemed USA, Inc. | 2025-03-28 |
| 76420-0928-90 | 90 TABLET in 1 BOTTLE (76420-928-90) | Ciprofloxacin | Asclemed USA, Inc. | 2025-03-28 |
| 76420-0929-01 | 100 TABLET in 1 BOTTLE (76420-929-01) | Ciprofloxacin | Asclemed USA, Inc. | 2025-03-28 |
| 76420-0929-05 | 500 TABLET in 1 BOTTLE (76420-929-05) | Ciprofloxacin | Asclemed USA, Inc. | 2025-03-28 |
| 76420-0929-14 | 14 TABLET in 1 BOTTLE (76420-929-14) | Ciprofloxacin | Asclemed USA, Inc. | 2026-06-27 |
| 76420-0929-20 | 20 TABLET in 1 BOTTLE (76420-929-20) | Ciprofloxacin | Asclemed USA, Inc. | 2025-03-28 |
| 76420-0929-30 | 30 TABLET in 1 BOTTLE (76420-929-30) | Ciprofloxacin | Asclemed USA, Inc. | 2025-03-28 |
| 76420-0929-60 | 60 TABLET in 1 BOTTLE (76420-929-60) | Ciprofloxacin | Asclemed USA, Inc. | 2025-03-28 |
| 76420-0929-90 | 90 TABLET in 1 BOTTLE (76420-929-90) | Ciprofloxacin | Asclemed USA, Inc. | 2025-03-28 |
| 82804-0256-06 | 6 TABLET in 1 BOTTLE (82804-256-06) | Ciprofloxacin | Proficient Rx LP | 2025-12-18 |
| 82804-0256-14 | 14 TABLET in 1 BOTTLE (82804-256-14) | Ciprofloxacin | Proficient Rx LP | 2026-04-13 |
| 82804-0256-20 | 20 TABLET in 1 BOTTLE (82804-256-20) | Ciprofloxacin | Proficient Rx LP | 2025-12-18 |
| 82868-0070-14 | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82868-070-14) | Ciprofloxacin | Northwind Health Company, LLC | 2025-02-10 |
| 82868-0070-20 | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82868-070-20) | Ciprofloxacin | Northwind Health Company, LLC | 2025-01-21 |
| 82868-0102-14 | 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82868-102-14) | ciprofloxacin | Northwind Health Company, LLC | 2026-02-12 |
| 85293-0002-01 | 100 TABLET in 1 BOTTLE (85293-002-01) | ciprofloxacin | Umasuto, LLC | 2025-03-05 |
| 85293-0003-01 | 100 TABLET in 1 BOTTLE (85293-003-01) | ciprofloxacin | Umasuto, LLC | 2025-03-05 |
| 85293-0004-01 | 100 TABLET in 1 BOTTLE (85293-004-01) | ciprofloxacin | Umasuto, LLC | 2025-03-05 |
| 85766-0099-01 | 100 TABLET in 1 BOTTLE (85766-099-01) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0099-10 | 10 TABLET in 1 BOTTLE (85766-099-10) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0099-20 | 20 TABLET in 1 BOTTLE (85766-099-20) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0099-30 | 30 TABLET in 1 BOTTLE (85766-099-30) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0099-60 | 60 TABLET in 1 BOTTLE (85766-099-60) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0099-90 | 90 TABLET in 1 BOTTLE (85766-099-90) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0100-01 | 100 TABLET in 1 BOTTLE (85766-100-01) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0100-10 | 10 TABLET in 1 BOTTLE (85766-100-10) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0100-20 | 20 TABLET in 1 BOTTLE (85766-100-20) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0100-30 | 30 TABLET in 1 BOTTLE (85766-100-30) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0100-60 | 60 TABLET in 1 BOTTLE (85766-100-60) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
| 85766-0100-90 | 90 TABLET in 1 BOTTLE (85766-100-90) | Ciprofloxacin | Sportpharm LLC | 2025-10-10 |
Observed labelers:
Bryant Ranch Prepack (61) ·
Proficient Rx LP (35) ·
Aurobindo Pharma Limited (22) ·
Asclemed USA, Inc. (18) ·
PD-Rx Pharmaceuticals, Inc. (17) ·
NuCare Pharmaceuticals,Inc. (15)
· +27 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.